News
Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least ...
Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...
Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...
20h
Barchart on MSNWeightWatchers Has Exited Bankruptcy. How Should You Play WW Stock Here?Among them, WW International (WW), formerly known as WeightWatchers, hit a rough patch earlier this year, resulting in WW ...
Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and ...
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
Gabapentin, which is used to treat seizures, nerve pain and restless leg syndrome might be linked with increased risk of ...
A labeling mistake has led to a nationwide recall of four different types of Ritz peanut butter cracker sandwich cartons, ...
1h
Arabian Post on MSNSingapore Welcomes Wegovy® as a New Prescription Weight‑Loss OptionA once-weekly injection of Wegovy® has become available in Singapore, marking the latest step in managing obesity as a ...
An updated edition of the June 4, 2025 article. The world is in the midst of a historic demographic shift with populations ...
Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.
19h
Zacks.com on MSNCan Mounjaro and Zepbound Drive Another Strong Quarter for Eli Lilly?LLY rides high on surging demand for Mounjaro and Zepbound, now nearly half its revenues ahead of Q2 earnings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results